Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KZIA Kazia Therapeutics Limited

盘前交易 12-17 04:12:08 EST

9.99

+0.48

+5.05%

最高12.20	最低9.65	成交量36.78万
今开9.65	昨收9.51	日振幅26.81%
总市值1.07亿	流通市值1.06亿	总股本1,073万
成交额388.40万	换手率3.48%	流通股本1,058万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KZIA","market":"US","secType":"STK","nameCN":"Kazia Therapeutics Limited","latestPrice":9.99,"timestamp":1765918800000,"preClose":9.51,"halted":0,"volume":367809,"delay":0,"floatShares":10583400,"shares":10732300,"eps":-12.38492,"marketStatus":"盘前交易","change":0.48,"latestTime":"12-17 04:12:08 EST","open":9.65,"high":12.2,"low":9.65,"amount":3883951.2260640003,"amplitude":0.268139,"askPrice":11.9,"askSize":100,"bidPrice":7.41,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-12.38492,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765981800000},"marketStatusCode":1,"adr":0,"adrRate":500,"exchange":"NASDAQ","adjPreClose":9.99,"postHourTrading":{"tag":"盘后","latestPrice":9.99,"preClose":9.99,"latestTime":"19:53 EST","volume":138,"amount":1434.5367,"timestamp":1765932782025},"volumeRatio":2.0455356892827687,"impliedVol":2.9646,"impliedVolPercentile":0.9012},"requestUrl":"/m/hq/s/KZIA/tweets","defaultTab":"tweets","newsList":[{"id":"2586491079","title":"Kazia Therapeutics Limited盘中异动 股价大跌7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586491079?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:49","pubTimestamp":1763999395,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时49分，Kazia Therapeutics Limited股票出现异动，股价急速跳水7.78%。截至发稿，该股报7.70美元/股，成交量3.1636万股，换手率1.89%，振幅6.57%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.79%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242349569517c089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242349569517c089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","KZIA","NVGNF"],"gpt_icon":0},{"id":"1148748436","title":"Kazia Therapeutics有限公司就Paxalisib的项目领跑者寻求FDA的反馈","url":"https://stock-news.laohu8.com/highlight/detail?id=1148748436","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148748436?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:21","pubTimestamp":1761564082,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics有限公司就Paxalisib的项目领跑者寻求FDA的反馈","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"1148501573","title":"Kazia Therapeutics计划请求FDA进行类型C会议，以讨论GBM的总体生存数据及潜在的NDA申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1148501573","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148501573?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:16","pubTimestamp":1761563768,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics计划请求FDA进行类型C会议，讨论于胶质母细胞瘤（GBM）中的总体生存数据，以及与FDA倡议项目“先锋者”（Project Frontrunner）相一致的潜在NDA申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2573747981","title":"Kazia Therapeutics Limited盘中异动 大幅拉升5.03%报6.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573747981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573747981?lang=zh_cn&edition=full","pubTime":"2025-10-07 00:26","pubTimestamp":1759767972,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日00时26分，Kazia Therapeutics Limited股票出现波动，股价大幅上涨5.03%。截至发稿，该股报6.89美元/股，成交量2.8339万股，换手率1.70%，振幅5.79%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.36%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007002612a6aefc85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007002612a6aefc85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","NVGNF","LENZ","KZIA"],"gpt_icon":0},{"id":"1111503317","title":"Kazia Therapeutics Limited宣布：Paxalisib联合免疫疗法使三阴性乳腺癌患者肿瘤缩小86%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111503317","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111503317?lang=zh_cn&edition=full","pubTime":"2025-10-02 20:33","pubTimestamp":1759408393,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited宣布：Paxalisib联合免疫疗法使三阴性乳腺癌患者肿瘤缩小86%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"1118445009","title":"Kazia Therapeutics Limited股价盘前大涨56% 公司乳腺癌疗法成功破坏肿瘤细胞簇","url":"https://stock-news.laohu8.com/highlight/detail?id=1118445009","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118445009?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:26","pubTimestamp":1757593573,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited股价在盘前交易中飙升56%，此前该公司宣布其乳腺癌治疗方案在破坏肿瘤细胞簇方面取得突破性进展。这一积极消息推动了投资者对该生物技术公司前景的乐观情绪，股价出现大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"1123909779","title":"Kazia Therapeutics宣布Paxalisib单药疗法在IV期HER2阳性乳腺癌中完全破坏大型循环肿瘤细胞集群的体外研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123909779","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123909779?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:01","pubTimestamp":1757592079,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics宣布Paxalisib单药疗法在IV期HER2阳性乳腺癌中完全破坏大型循环肿瘤细胞集群的体外研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2563834498","title":"Kazia Therapeutics Limited盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563834498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563834498?lang=zh_cn&edition=full","pubTime":"2025-08-30 00:04","pubTimestamp":1756483462,"startTime":"0","endTime":"0","summary":"北京时间2025年08月30日00时04分，Kazia Therapeutics Limited股票出现异动，股价快速拉升5.35%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Briacell Therapeutics Corp C/Wts 26/02/2026、Vivosim Labs, Inc.、Inflarx N.V.涨幅较大，Tnf Pharmaceuticals, Inc.、Vivosim Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为36807.70%、263.62%、113.30%，振幅较大的相关个股有Vivosim Labs, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Relmada Therapeutics, Inc.，振幅分别为62.03%、56.67%、46.44%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508300004229505ee47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508300004229505ee47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","NVGNF","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2561142618","title":"Kazia Therapeutics Limited盘中异动 大幅拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561142618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561142618?lang=zh_cn&edition=full","pubTime":"2025-08-22 00:29","pubTimestamp":1755793740,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日00时29分，Kazia Therapeutics Limited股票出现异动，股价大幅拉升6.14%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、知临集团、Protagenic Therapeutics, Inc.涨幅较大，Protagenic Therapeutics, Inc.、知临集团、Tharimmune, Inc.较为活跃，换手率分别为15960.34%、3842.65%、1391.53%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、知临集团，振幅分别为459.84%、116.23%、113.39%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822002900a496a9d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822002900a496a9d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","BK4007","LENZ","BK4139","NVGNF","BK4539"],"gpt_icon":0},{"id":"2550560488","title":"Kazia Therapeutics Limited7月10日成交额为786.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550560488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550560488?lang=zh_cn&edition=full","pubTime":"2025-07-11 11:14","pubTimestamp":1752203696,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Kazia Therapeutics Limited成交额为786.68万美元，成交额较昨日减少92.23%，当日成交量为76.65万股。Kazia Therapeutics Limited于2025年7月10日涨8.71%，报10.36美元，该股过去5个交易日涨57.45%，年初至今涨17.06%，过去60日涨169.09%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib；用于治疗卵巢癌的Cantrixil；和一些其他药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711111459a6a2ccb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711111459a6a2ccb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","BK4139","KZIA","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2550899699","title":"Kazia Therapeutics Limited7月9日成交额为1.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550899699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550899699?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:12","pubTimestamp":1752117164,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Kazia Therapeutics Limited成交额为1.01亿美元，成交额较昨日增加4787.10%，当日成交量为1069.82万股。Kazia Therapeutics Limited于2025年7月9日涨39.63%，报9.53美元，该股过去5个交易日涨43.74%，年初至今涨7.68%，过去60日涨161.1%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib；用于治疗卵巢癌的Cantrixil；和一些其他药物。该公司还在开发用于治疗各种肿瘤的EVT801。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710111246a6a09f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710111246a6a09f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","KZIA","LENZ","BK4007","BK4139","NVGNF"],"gpt_icon":0},{"id":"2548825301","title":"Kazia Therapeutics Limited7月2日成交额为7.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548825301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548825301?lang=zh_cn&edition=full","pubTime":"2025-07-03 11:12","pubTimestamp":1751512326,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Kazia Therapeutics Limited成交额为7.59万美元，成交额较昨日减少62.12%，当日成交量为1.17万股。Kazia Therapeutics Limited于2025年7月2日跌0.75%，报6.58美元，该股过去5个交易日跌0.15%，年初至今跌25.65%，过去60日涨85.09%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib；用于治疗卵巢癌的Cantrixil；和一些其他药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703111213a72bc0b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703111213a72bc0b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","BK4139","KZIA","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2546775350","title":"Kazia Therapeutics Limited6月27日成交额为37.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546775350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546775350?lang=zh_cn&edition=full","pubTime":"2025-06-28 11:07","pubTimestamp":1751080035,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Kazia Therapeutics Limited成交额为37.42万美元，成交额较昨日增加320.12%，当日成交量为6.02万股。Kazia Therapeutics Limited于2025年6月27日跌2.99%，报6.34美元，该股过去5个交易日跌30.77%，年初至今跌28.42%，过去60日涨58.97%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib；用于治疗卵巢癌的Cantrixil；和一些其他药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628110717a4c25459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628110717a4c25459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","NVGNF","BK4007","KZIA"],"gpt_icon":0},{"id":"2518222567","title":"Kazia Therapeutics Limited盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222567?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分，Kazia Therapeutics Limited股票出现波动，股价大幅下挫5.08%。截至发稿，该股报1.12美元/股，成交量19.3999万股，换手率3.47%，振幅5.08%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.42%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633abf2fe3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633abf2fe3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","NVGNF","BK4139","LENZ"],"gpt_icon":0},{"id":"2517161311","title":"Kazia Therapeutics Limited盘中异动 大幅拉升7.33%报0.848美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161311?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:59","pubTimestamp":1741273143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时59分，Kazia Therapeutics Limited股票出现波动，股价急速拉升7.33%。截至发稿，该股报0.848美元/股，成交量1165股，换手率0.02%，振幅7.33%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.63%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225903abeb7e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225903abeb7e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZIA","LENZ","NVGNF"],"gpt_icon":0},{"id":"2517948806","title":"Kazia Therapeutics Limited盘中异动 股价大涨6.06%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948806?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Kazia Therapeutics Limited股票出现异动，股价大幅拉升6.06%。截至发稿，该股报0.810美元/股，成交量4.5971万股，换手率0.82%，振幅0.00%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.20%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223223abe9b0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223223abe9b0fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","LENZ","NVGNF","BK4139"],"gpt_icon":0},{"id":"2517833819","title":"Kazia Therapeutics Limited盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517833819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517833819?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:33","pubTimestamp":1741116814,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时33分，Kazia Therapeutics Limited股票出现波动，股价大幅跳水5.16%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1311.19%、1224.04%、1209.16%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033334a25f57f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033334a25f57f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","LENZ","BK4139","KZIA"],"gpt_icon":0},{"id":"2514861729","title":"Kazia Therapeutics Limited盘中异动 急速上涨5.62%报0.864美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861729?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:38","pubTimestamp":1740598693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时38分，Kazia Therapeutics Limited股票出现异动，股价急速上涨5.62%。截至发稿，该股报0.864美元/股，成交量3.8845万股，换手率0.69%，振幅5.28%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.47%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270338139631862c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270338139631862c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZIA","LENZ","NVGNF"],"gpt_icon":0},{"id":"2514016510","title":"Kazia Therapeutics Limited盘中异动 早盘股价大跌8.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016510?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:30","pubTimestamp":1740497415,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时30分，Kazia Therapeutics Limited股票出现异动，股价大幅下跌8.34%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1070.68%、947.53%、593.23%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233015a253950e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233015a253950e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZIA","LENZ","NVGNF"],"gpt_icon":0},{"id":"2512348187","title":"Kazia Therapeutics Limited盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512348187?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:02","pubTimestamp":1739980942,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时02分，Kazia Therapeutics Limited股票出现异动，股价急速下挫5.00%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为561.88%、242.60%、178.48%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000223a24c0cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000223a24c0cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZIA","LENZ","NVGNF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kaziatherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.3584},{"period":"1month","weight":0.5933},{"period":"3month","weight":0.2582},{"period":"6month","weight":0.1212},{"period":"1year","weight":-0.4},{"period":"ytd","weight":0.1288}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kazia Therapeutics Limited成立于1994年3月，注册地为澳大利亚新南威尔士州。该公司从事药物开发，主要专注于肿瘤学。Kazia是一家新兴的生物技术企业，拥有涵盖多种技术的开发候选产品组合，旨在推进针对各种癌症适应症的创新疗法，并提供解决未满足的医疗需求的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.05951},{"month":2,"riseRate":0.259259,"avgChangeRate":0.016352},{"month":3,"riseRate":0.518519,"avgChangeRate":0.052977},{"month":4,"riseRate":0.407407,"avgChangeRate":0.002336},{"month":5,"riseRate":0.296296,"avgChangeRate":-0.02903},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.056841},{"month":7,"riseRate":0.37037,"avgChangeRate":0.010347},{"month":8,"riseRate":0.407407,"avgChangeRate":0.002958},{"month":9,"riseRate":0.481481,"avgChangeRate":-0.003545},{"month":10,"riseRate":0.37037,"avgChangeRate":-0.038599},{"month":11,"riseRate":0.481481,"avgChangeRate":0.165037},{"month":12,"riseRate":0.407407,"avgChangeRate":-0.037282}],"exchange":"NASDAQ","name":"Kazia Therapeutics Limited","nameEN":"Kazia Therapeutics Limited"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kazia Therapeutics Limited(KZIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kazia Therapeutics Limited,KZIA,Kazia Therapeutics Limited股票,Kazia Therapeutics Limited股票老虎,Kazia Therapeutics Limited股票老虎国际,Kazia Therapeutics Limited行情,Kazia Therapeutics Limited股票行情,Kazia Therapeutics Limited股价,Kazia Therapeutics Limited股市,Kazia Therapeutics Limited股票价格,Kazia Therapeutics Limited股票交易,Kazia Therapeutics Limited股票购买,Kazia Therapeutics Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kazia Therapeutics Limited(KZIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}